Publications by authors named "F G Coury"

Claim this Profile
E
Exploring the relative influence of atomic parameters on solid solution strengthening.
P H F Oliveira, C L G P Martins, G C Stumpf, J Spadotto, E J Pickering, F G Coury

Nat Commun· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT).
Hubert Marotte, Alain Cantagrel, Fabienne Coury, Thierry Schaeverbeke, Maryse Assing

Adv Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal and influenza vaccination coverage and impact on COVID-19 infection severity in patients with inflammatory rheumatic diseases: A French National Healthcare Database analysis.
Maxime Auroux, Thibaut Fabacher, Erik Sauleau, Laurent Arnaud, Fabienne Coury

Vaccine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with severity and mortality of COVID-19 in patients with connective tissue diseases and rheumatoid arthritis: A nation-wide, population-based analysis of the French national medico-administrative SNDS database.
Lou Kawka, Thibaut Fabacher, Erik Sauleau, Fabienne Coury, Laurent Arnaud

Joint Bone Spine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study.
Bruno Fautrel, Yoram Bouhnik, Carine Salliot, Franck Carbonnel, Mathurin Fumery, Fabienne Coury

Drugs Real World Outcomes· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis